These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26437792)
1. Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo. Isa K; Oka K; Beauchamp N; Sato M; Wada K; Ohtani K; Nakanishi S; McCartney E; Tanaka M; Shimizu T; Kamiya S; Kruger C; Takahashi M Hum Exp Toxicol; 2016 Aug; 35(8):818-32. PubMed ID: 26437792 [TBL] [Abstract][Full Text] [Related]
2. The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue. Hagihara M; Yamashita R; Matsumoto A; Mori T; Kuroki Y; Kudo H; Oka K; Takahashi M; Nonogaki T; Yamagishi Y; Mikamo H Anaerobe; 2018 Dec; 54():8-18. PubMed ID: 30076897 [TBL] [Abstract][Full Text] [Related]
3. The impact of probiotic Clostridium butyricum MIYAIRI 588 on murine gut metabolic alterations. Hagihara M; Yamashita R; Matsumoto A; Mori T; Inagaki T; Nonogaki T; Kuroki Y; Higashi S; Oka K; Takahashi M; Mikamo H J Infect Chemother; 2019 Aug; 25(8):571-577. PubMed ID: 31101528 [TBL] [Abstract][Full Text] [Related]
4. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Seki H; Shiohara M; Matsumura T; Miyagawa N; Tanaka M; Komiyama A; Kurata S Pediatr Int; 2003 Feb; 45(1):86-90. PubMed ID: 12654076 [TBL] [Abstract][Full Text] [Related]
5. Kato M; Hamazaki Y; Sun S; Nishikawa Y; Kage-Nakadai E Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563064 [No Abstract] [Full Text] [Related]
6. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain. Woo TDH; Oka K; Takahashi M; Hojo F; Osaki T; Hanawa T; Kurata S; Yonezawa H; Kamiya S J Med Microbiol; 2011 Nov; 60(Pt 11):1617-1625. PubMed ID: 21700738 [TBL] [Abstract][Full Text] [Related]
7. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571 [TBL] [Abstract][Full Text] [Related]
8. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Popoff MR; Bouvet P Toxicon; 2013 Dec; 75():63-89. PubMed ID: 23707611 [TBL] [Abstract][Full Text] [Related]
9. Novel Putative Transposable Element Associated with the Subtype E5 Botulinum Toxin Gene Cluster of Neurotoxigenic Li T; Ning N; Iacobino A; Zhang L; Wang H; Franciosa G Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055088 [TBL] [Abstract][Full Text] [Related]
10. Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea. Ling Z; Liu X; Cheng Y; Luo Y; Yuan L; Li L; Xiang C Biomed Res Int; 2015; 2015():582048. PubMed ID: 25802855 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation on adherence and antimicrobial properties of a candidate probiotic Clostridium butyricum CB2 for farmed fish. Pan X; Wu T; Zhang L; Song Z; Tang H; Zhao Z J Appl Microbiol; 2008 Nov; 105(5):1623-9. PubMed ID: 18795975 [TBL] [Abstract][Full Text] [Related]
12. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum. Fach P; Micheau P; Mazuet C; Perelle S; Popoff M J Appl Microbiol; 2009 Aug; 107(2):465-73. PubMed ID: 19291235 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and resistance determinants of Clostridium butyricum isolates from preterm infants. Ferraris L; Butel MJ; Aires J Int J Antimicrob Agents; 2010 Nov; 36(5):420-3. PubMed ID: 20822886 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of probiotic Clostridium butyricum WZ001 on bacterial vaginosis in mice. Zhou Y; Xu W; Hong K; Li H; Zhang J; Chen X; Zhu Y; Zhang Q; Ding F; Wang F J Appl Microbiol; 2019 Aug; 127(2):565-575. PubMed ID: 31102489 [TBL] [Abstract][Full Text] [Related]
15. Supplemental Clostridium butyricum MIYAIRI 588 Affects Intestinal Bacterial Composition of Finishing Pigs. Hirata M; Matsuoka M; Hashimoto T; Oura T; Ohnuki Y; Yoshida C; Minemura A; Miura D; Oka K; Takahashi M; Morimatsu F Microbes Environ; 2022; 37(3):. PubMed ID: 36155363 [TBL] [Abstract][Full Text] [Related]
16. Establishment of an Endogenous Oka K; Osaki T; Hanawa T; Kurata S; Sugiyama E; Takahashi M; Tanaka M; Taguchi H; Kamiya S Front Microbiol; 2018; 9():1264. PubMed ID: 29967595 [No Abstract] [Full Text] [Related]
17. Identification and Characterization of a Potential Probiotic, Clostridium butyricum G13, Isolated from the Intestine of the Mud Crab (Scylla paramamosain). Liang H; Tran NT; Deng T; Li J; Lei Y; Bakky MAH; Zhang M; Li R; Chen W; Zhang Y; Chen X; Li S Microbiol Spectr; 2023 Aug; 11(4):e0131723. PubMed ID: 37522814 [TBL] [Abstract][Full Text] [Related]
18. Pangenome analyses of Clostridium butyricum provide insights into its genetic characteristics and industrial application. Yang Y; Shao Y; Pei C; Liu Y; Zhang M; Zhu X; Li J; Feng L; Li G; Li K; Liang Y; Li Y Genomics; 2024 May; 116(3):110855. PubMed ID: 38703968 [TBL] [Abstract][Full Text] [Related]
19. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Steppe M; Van Nieuwerburgh F; Vercauteren G; Boyen F; Eeckhaut V; Deforce D; Haesebrouck F; Ducatelle R; Van Immerseel F Food Chem Toxicol; 2014 Oct; 72():129-37. PubMed ID: 25007784 [TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of two bacterial strains used in Asian probiotic products. Tompkins TA; Hagen KE; Wallace TD; Fillion-Forté V Can J Microbiol; 2008 May; 54(5):391-400. PubMed ID: 18449224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]